BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
PRODID:-//Virginia Tech//VTCalendar//EN
BEGIN:VEVENT
DTSTAMP:20121206T223000Z
UID:1354396525308@www.calendar.vt.edu
CATEGORIES:VTC
DTSTART:20121206T223000Z
DTEND:20121206T233000Z
SUMMARY:Personalized Cancer Medicine: Are We There Yet?
DESCRIPTION:
Eileen Dolan, PhD\n
Professor
of Medicine, Section of Hematology/Oncology\n
Co-Director, Clinical and Experimental Therapeutics
Program of the Comprehensive Cancer Center\n
University
of Chicago, Illinois \n
\n
A
public lecture in the Distinguished
Scholars
Series\n
\n
A primary aim
of pharmacogenomics is to devise personalized
treatment strategies based on an individual's
genetic makeup to maximize the potential
for therapeutic benefit and minimize the risk
of adverse side effects. Dr. Dolan will discuss
the role of pharmacogenomics in cancer research,
a field in which personalized drug therapy
is especially desirable given the narrow
therapeutic index and life-threatening consequences
of drug toxicity.\n
\n
Live Webcast: http://research.vtc.vt.edu/live-webcast\n
\n
A
public reception will be held in
the VTC Cafe at 5:00 p.m.\n
\n
Hosted by: Michael
J. Friedlander, PhD, Executive Director,
Virginia Tech Carilion Research Institute\n\n
Price: Free\n
Sponsor: Virginia Tech Carilion Research Institute\n
Homepage: http://research.vtc.vt.edu\n
Contact: Michael Friedlander\n
Phone: 540-526-2013\n
E-Mail:: vtcri-scholars@vtc.vt.edu\n
for more info visit the web at:\n
http://research.vtc.vt.edu/events/2012/dec/06/personalized-cancer-medicine-are-we-there-yet/\n
LOCATION:Virginia Tech Carilion Research Institute, 2 Riverside Circle, Roanoke
END:VEVENT
END:VCALENDAR